In 2013, AbbVie (NYSE: ABBV) became a publicly traded entity after separating from Abbott Laboratories (NYSE: ABT), both of which have provided strong returns and consistent dividend increases for income investors. These healthcare companies are expected to continue rewarding shareholders with ongoing payout hikes in the future.
Explain It To Me Like I’m 5: AbbVie and Abbott Laboratories are two companies that make medicine and have been doing really well, making their investors happy by giving them more money often.
Want More Context? 🔎
Loading PerspectiveSplit analysis...
